|Suppliers: see list||2|
|Therapeutic Class:||Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)|
|Active Rx/OTC/Discontinued:||RX||Dosage:||INSERT, EXTENDED RELEASE; VAGINAL||Strength||EQ 0.05MG BASE/24HR|
|Approval Date:||Mar 20, 2003||TE:||RLD:||No|
|Patent:||5,855,906||Patent Expiration:||Dec 19, 2015||Product Flag?||Substance Flag?||Delist Request?|
|Patented Use:||METHOD OF RELEASING 17-BETA OESTRADIOL PRECURSOR IN A SUBSTANTIALLY ZERO ORDER PATTERN FOR AT LEAST THREE WEEKS|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.